PRESS RELEASE
6 September 2023

Director’s Cut: A Retrospective On Vidal’s Tenure At The PTAB

MF
Morrison & Foerster LLP
Contributor
Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
Director Kathi Vidal of the U.S. Patent and Trademark Office has made an impact at the PTO over the past 18 months. Our Patent Trial and Appeal Board attorneys will discuss...
United States
To print this article, all you need is to be registered or login on Mondaq.com.

26 Oct 2023

REGISTER

Director Kathi Vidal of the U.S. Patent and Trademark Office has made an impact at the PTO over the past 18 months. Our Patent Trial and Appeal Board attorneys will discuss these recent developments and what they mean for patent owners and petitioners facing proceedings before the PTAB, including:

  • Discontinuance of Precedential-Opinion-Panel (POP) panels in favor of Director Review and Appeals Review Panel
  • Review of notable Director Review decisions
  • Advanced Notice of Proposed Rulemaking
PRESS RELEASE
6 September 2023

Director’s Cut: A Retrospective On Vidal’s Tenure At The PTAB

United States
Contributor
Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More